We did not come across literature that specifically demonstrated a relationship between the CD4 count and the progression of vulvar cancer; however, there is evidence that suggests that ART for HIV causes a modest 30.0% reduction of HPV clearance.24 Further studies are needed to determine the impact of CD4 count on disease progression. This evidence concerns the gene CD4 and vulva cancer.